Edition:
United Kingdom

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

39.18SEK
5:00pm BST
Change (% chg)

0.32kr (+0.82%)
Prev Close
38.86kr
Open
38.32kr
Day's High
39.38kr
Day's Low
38.32kr
Volume
63,890
Avg. Vol
404,115
52-wk High
45.35kr
52-wk Low
25.25kr

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 463.27 0.167
Sep '18 395.33 0.340
Jun '18 489.45 3.860
Mar '18 267.06 0.424
FY 2017 Dec '17 238.72 -0.399
Sep '17 137.09 0.128
Jun '17 142.46 0.176
Mar '17 139.33 0.231
 
*Note: Units in Millions ofSwedish Krona
**Note: Units in Swedish Krona

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-19 1 2,027.00 2,027.00 2,027.00 2,027.00
Year Ending Dec-20 1 2,241.00 2,241.00 2,241.00 2,241.00
Earnings (per share)
Year Ending Dec-19 1 2.07 2.07 2.07 2.18
Year Ending Dec-20 1 2.47 2.47 2.47 --
Sales and Profit Figures in Swedish Krona (SEK);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 8.11 110.59 62.94
P/E High - Last 5 Yrs. 194.36 162.88 56.44
P/E Low - Last 5 Yrs. 8.00 52.22 28.76
Beta 0.42 1.17 0.93
Price to Sales (TTM) 3.95 45.83 9.69
Price to Book (MRQ) 1.77 13.27 4.53
Price to Tangible Book (MRQ) -- 18.94 8.07
Price to Cash Flow (TTM) 7.30 73.77 43.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.09 1.54
Dividend Yield - 5 Year Avg 0.42 0.05 0.70
Dividend 5 Year Growth Rate -- 0.71 2.98
Payout Ratio(TTM) 0.00 8.47 21.89

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 94.07 22.25 9.11
Sales (TTM) vs TTM 1 Yr. Ago 145.60 66.82 8.34
Sales - 5 Yr. Growth Rate 102.85 33.24 11.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 141.84 -90.31 112.52
EPS (TTM) vs TTM 1 Yr. Ago 3,173.52 -- --
EPS - 5 Yr. Growth Rate -- 21.66 6.94
Capital Spending - 5 Yr. Growth Rate 12.43 25.54 7.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.81 2.67
Current Ratio (MRQ) 0.71 3.64 3.63
LT Debt to Equity (MRQ) 50.85 7.02 13.38
Total Debt to Equity (MRQ) 50.85 20.04 17.12
Interest Coverage (TTM) 1.35 11.13 27.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 58.12 25.49 50.33
Gross Margin - 5 Yr. Avg. -- 60.05 50.77
EBITD Margin (TTM) 39.14 -- --
EBITD - 5 Yr. Avg 25.38 -10.78 15.75
Operating Margin (TTM) 25.65 -108.32 -2.12
Operating Margin - 5 Yr. Avg. 14.32 -26.36 11.07
Pre-Tax Margin (TTM) 17.97 -109.04 -2.97
Pre-Tax Margin - 5 Yr. Avg. 7.22 -29.08 16.81
Net Profit Margin (TTM) 40.70 -115.42 -6.92
Net Profit Margin - 5 Yr. Avg. 23.17 -34.27 11.75
Effective Tax Rate (TTM) -126.56 19.94 22.89
Effective Tax Rate - 5 Yr. Avg. -220.97 19.62 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 17,945,640 8,473,856 767,389,378
Net Income/Employee (TTM) 7,304,367 1,875,927 88,365,779
Receivable Turnover (TTM) -- 2.36 5.22
Inventory Turnover (TTM) -- 2.32 3.64
Asset Turnover (TTM) 0.29 0.32 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 11.92 6.37 9.51
Return on Assets - 5 Yr. Avg. 6.25 6.26 10.45
Return on Investment (TTM) 15.08 8.01 11.75
Return on Investment - 5 Yr. Avg. 8.17 8.20 13.34
Return on Equity (TTM) 25.30 8.19 12.58
Return on Equity - 5 Yr. Avg. 13.93 9.32 14.82
  1 Year 3 Year 5 Year
Sales % 145.60 185.92 102.85
EPS (TTM) % 2,754.80 -- --
Dividend % -100.00 -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.94 -2.54 99 91
13 Week 2.94 -8.22 99 82
26 Week 19.75 10.56 99 9
52 Week 25.83 15.67 99 27
YTD 4.89 -11.12 81 28
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.81%
# of Holders: 24
Total Shares Held: 111,434,815
3 Mo. Net Change: 69,150,408
# New Positions: 1
# Closed Positions: 9
# Increased Positions: 4
# Reduced Positions: 16
# Net Buyers: -12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.